Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
China National MedicinesSHSE:600511 -0.04%90 Days Inventory is 39.17 as of Jun. 2026, which is 26% above its 10-year median of 31.03. GuruFocus rates SHSE:600511 with a GF Score™ of 90/100 and a GF Value™ of ¥32.09 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 117 Medical Distribution companies, China National Medicines ranks better than 63.25% on this metric.
The historical rank and industry rank for China National Medicines's Days Inventory or its related term are showing as below:
SHSE:600511'
s Days Inventory Range Over the Past 10 Years
Min: 21.65 Med: 31.03 Max: 38.35
Current: 38.35
During the past 13 years, China National Medicines's highest Days Inventory was 38.35. The lowest was 21.65. And the median was 31.03.
SHSE:600511's Days Inventory is ranked better than 63.25% of 117
companies
in the Medical Distribution industry
Industry Median: 54.88
vs SHSE:600511: 38.35
Inventory Turnover measures how fast the company turns over its inventory within a year.
China National Medicines's Inventory Turnover for the
three
months ended in Jun. 2026 was 2.33.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
China National Medicines's Inventory-to-Revenue for the
three
months ended in Jun. 2026 was 0.40.
China National Medicines (SHSE:600511) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
China National Medicines's Inventory Turnover for the
three
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
China National Medicines's Inventory to Revenue for the
three
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
China National Medicines Days Inventory Related Terms
China National Medicines Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:600511 vs MCK, COR, CAH: Days Inventory Comparison
For the Medical Distribution subindustry, China National Medicines's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China National Medicines Days Inventory vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, China National Medicines's Days Inventory distribution charts can be found below:
* The bar in red indicates where China National Medicines's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China National Medicines (SHSE:600511) has a Days Inventory of 39.17 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on China National Medicines and its competitors. This is 26% above median its historical median of 31.03. Over the past decade, China National Medicines' Days Inventory has ranged from 21.65 to 38.35. According to the industry distribution chart, China National Medicines ranks #43 out of 117 companies in the Medical Distribution industry, placing it in the top 36.8%.
Is China National Medicines' Days Inventory too high?
China National Medicines' current Days Inventory of 39.17 is 26% above median its 10-year median of 31.03. Over the past 10 years, this metric has ranged from a low of 21.65 to a high of 38.35. The Medical Distribution industry median Days Inventory is 54.88. China National Medicines' value of 39.17 is 28.6% below this industry median. Based on the distribution chart, China National Medicines ranks #43 out of 117 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, China National Medicines has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does China National Medicines' Days Inventory compare to MCK and COR?
According to the Medical Distribution industry distribution chart, China National Medicines ranks #43 out of 117 companies for Days Inventory. This puts China National Medicines in the upper half of its industry. The industry median Days Inventory is 54.88. China National Medicines' value of 39.17 is 28.6% below this benchmark. Historically, China National Medicines' own Days Inventory has ranged from 21.65 to 38.35 over the past decade. While the company's 10-year median is 31.03 vs. the industry median of 54.88, China National Medicines has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Distribution company?
The median Days Inventory among Medical Distribution companies is 54.88, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China National Medicines's current Days Inventory of 39.17 is 28.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on China National Medicines and its competitors. For the Medical Distribution industry, the median Days Inventory is 54.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China National Medicines's current Days Inventory is 39.17, which is 26% above median its own 10-year median of 31.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China National Medicines stock overvalued right now?
Based on GuruFocus' analysis, China National Medicines (SHSE:600511) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥32.09, compared to a current price of ¥26.77 — trading 16.6% below its estimated fair value. The current Days Inventory is 39.17, which is 26% above median its 10-year median of 31.03 and 28.6% below the Medical Distribution industry median of 54.88. China National Medicines' overall GF Score™ is 90/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For China National Medicines (SHSE:600511), the current Days Inventory is 39.17 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China National Medicines (SHSE:600511) Overvalued in 2026?
Based on GuruFocus' analysis, China National Medicines stock appears to be undervalued.
The current stock price of ¥26.77 is trading 16.6% below its estimated GF Value™ of ¥32.09.
GuruFocus considers China National Medicines to be Modestly Undervalued.
Key valuation signals for SHSE:600511:
Days Inventory: 39.17 (26% above median its 10-year median of 31.03)
GF Value™: ¥32.09 vs. price of ¥26.77 (16.6% below fair value)
Industry Position: 28.6% below the Medical Distribution median (#43 of 117)
No single metric tells the full story. See the SHSE:600511 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China National Medicines Corp Ltd focuses on producing special drugs and high-end prescription drugs. Its main goal is to provide customers with professional medical services. The company conducts its operations through two primary segments. The Commercial segment is mainly engaged in the sale of pharmaceuticals. The Others segment focuses on pharmaceutical manufacturing and logistics operations.
90GF Score
Get the complete analysis for SHSE:600511
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600511 has been successfully added to your 
